ArriVent BioPharma, Inc. Quarterly Operating Lease, Liability, Noncurrent in USD from Q4 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
ArriVent BioPharma, Inc. quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q4 2023 to Q3 2024.
  • ArriVent BioPharma, Inc. Operating Lease, Liability, Noncurrent for the quarter ending September 30, 2024 was $56K.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $56K Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $98K Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $138K Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $177K Dec 31, 2023 10-Q 2024-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.